With the coronavirus pandemic continuing its deadly run by infecting more than a million people and causing the death of more than 82,000 people across the world, the laboratories of the Council of Scientific and Industrial Research (CSIR) intensified their efforts at combating the pandemic.

Surveillance at the level of the virus, humans, and geographical origins and distributions is a critical step in combating Covid-19.

Ever since the Coronavirus pandemic broke out, CSIR has mounted a strategic, well-coordinated and integrated approach towards mitigating the Coronavirus outbreak.

CSIR has been leading the fight against COVID-19 and contributing extensively to overcome the deadly coronavirus outbreak.

Higher testing capacity is essential to mitigate the continued spread of the virus.

A simple, sensitive and rapid method to detect the virus using a targeted mass spectrometric approach.

Ten doctors and technicians from the ESI Medical College and Hospital, Chennai, were provided training in COVID 19 diagnosis.

The CRISPR-Cas9-based test developed by CSIR-IGIB in collaboration with Tata Sons recently received regulatory approval from the Drugs Controller General of India (DCGI) for commercial launch, as per ICMR guidelines.

The study is a step towards a better understanding of the infection recovery and re-infection pattern.

The study would look into the efficacy/action of mono-herbal formulations of whole extracts of Vasa and Guduchi respectively, and polyherbal formulation of Vasa-Guduchi whole extract.

CSIR Success Stories Webinar Series

Jigyasa Vigyan Mahotsav 2022

Webinar series on 'Stem Cells: Basics to Applications'

CSIR-IGIB organises various programmes during the event.

Overall, the engineered FnCas9 variants represent a significant leap forward in genome editing, offering enhanced precision, flexibility, and potential for therapeutic applications.